NervGen Pharma (TSXV:NGEN) Other Current Payables : C$0.44 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is NervGen Pharma Other Current Payables?

NervGen Pharma's Other Current Payables for the quarter that ended in Dec. 2023 was C$0.44 Mil.

NervGen Pharma's quarterly Other Current Payables increased from Jun. 2023 (C$0.26 Mil) to Sep. 2023 (C$0.46 Mil) but then declined from Sep. 2023 (C$0.46 Mil) to Dec. 2023 (C$0.44 Mil).

NervGen Pharma's annual Other Current Payables increased from Dec. 2021 (C$0.27 Mil) to Dec. 2022 (C$0.50 Mil) but then declined from Dec. 2022 (C$0.50 Mil) to Dec. 2023 (C$0.44 Mil).

NervGen Pharma Other Current Payables Historical Data

The historical data trend for NervGen Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NervGen Pharma Other Current Payables Chart

NervGen Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Current Payables

Get a 7-Day Free Trial

0.17

0.16

0.27

0.50

0.44

NervGen Pharma Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Current Payables	Get a 7-Day Free Trial															0.50	0.13	0.26	0.46	0.44

NervGen Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

NervGen Pharma Other Current Payables Related Terms

Thank you for viewing the detailed overview of NervGen Pharma's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.

NervGen Pharma (TSXV:NGEN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NervGen Pharma Corp (TSXV:NGEN) » Definitions » Other Current Payables

Comparable Companies

Traded in Other Exchanges

NGENF:USA 9UA:Germany

Address

2955 Virtual Way, Suite 480, Vancouver, BC, CAN, V5M 4X6

Website

https://www.nervgen.com

NervGen Pharma Corp is a biotech company dedicated to creating innovative solutions for the treatment of nerve damage and neurodegenerative diseases. The company is developing drugs for the treatment of spinal cord injury, multiple sclerosis, and Alzheimer's disease. It operates in a single segment, which is the research and development of pharmaceutical drugs.

NervGen Pharma (TSXV:NGEN) Headlines

No Headlines